4.7 Article

Killing of non-replicating Mycobacterium tuberculosis by 8-hydroxyquinoline

期刊

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
卷 65, 期 7, 页码 1424-1427

出版社

OXFORD UNIV PRESS
DOI: 10.1093/jac/dkq145

关键词

M. tuberculosis; TB; hydroxyquinolines

资金

  1. Bill and Melinda Gates Foundation [42672]
  2. Milstein Program in Chemical Biology of Infectious Disease
  3. William Randolph Hearst Foundation

向作者/读者索取更多资源

Objectives: To determine the effect of 8-hydroxyquinoline (8HQ) on non-replicating Mycobacterium tuberculosis (Mtb) in comparison with its reported effect on replicating Mtb. Methods: The MIC of 8HQ for replicating H37Rv Mtb was determined by microdilution in 7H9 broth. Bactericidal activity was determined by exposing H37Rv Mtb to 8HQ for 4 days under conditions that otherwise allowed exponential replication (20% O-2, pH 6.6) and conditions under which replication was precluded: 1% O-2, pH 6.6; 20% O-2, pH 5.5; or 20% O-2, pH 5.5, 0.5 mM sodium nitrite. Serial dilutions were plated on 7H11 agar to quantify cfu. Frequency of resistance (FOR) was determined with >10(9) bacteria plated on 7H9 agar plates containing 2x MIC 8HQ. Results: 8HQ was active against replicating Mtb (MIC 2.5 mu M, 0.36 mg/L). Under both replicating and non-replicating conditions, cfu were reduced in 4 days by >= 5 log(10) at the highest concentration tested (10 mu M). Bactericidal activity was maximal at low pH, where 8HQ reduced cfu by 1-1.5 log(10) at 1 mu M. We were unable to recover any 8HQ-resistant colonies. Conclusions: This study demonstrates that 8HQ has bactericidal activity of comparable potency against non-replicating and replicating Mtb, a property not observed for anti-infective agents currently approved for treatment of tuberculosis, and a very low FOR. Drugs with these properties are urgently needed to shorten the course of treatment for both active and latent tuberculosis.\

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据